HINOON logo

Highnoon Laboratories Limited Stock Price

KASE:HINOON Community·PK₨51.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 31 Fair Values set on narratives written by author

HINOON Share Price Performance

PK₨0
-1076.59 (-100.00%)
PK₨0
-1076.59 (-100.00%)
Price PK₨0

HINOON Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record and pays a dividend.

2 Risks
3 Rewards

Highnoon Laboratories Limited Key Details

PK₨28.2b

Revenue

PK₨12.3b

Cost of Revenue

PK₨15.9b

Gross Profit

PK₨11.7b

Other Expenses

PK₨4.2b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
79.68
56.34%
14.97%
5.7%
View Full Analysis

About HINOON

Founded
1984
Employees
2563
CEO
Adeel Haider
WebsiteView website
highnoon-labs.com

Highnoon Laboratories Limited, together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally. The company offers medicines in various drug forms and brands for allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynecology, pediatrics, respiratory, and urology therapeutic areas. It exports its products. The company was incorporated in 1984 and is based in Lahore, Pakistan.

Recent HINOON News & Updates

Recent updates

No updates

Highnoon Laboratories Limited Competitors